Inventor · disambiguated record
Fengjiang Wang
Also filed as: WANG FENGJIANG
25 granted patents·2 pending applications·294 citations·filing 1997–2017
96Inventor score
Top patents by PatentIndex Score
27 records- 0196US7294637B2Method of treating addiction or dependence using a ligand for a monamine receptor or transporterSEPRACOR INC·Filed 2004·Granted Nov 13, 2007·89 cites·35 claims
- 0295US6645980B1Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2000·Granted Nov 11, 2003·46 cites·21 claims
- 0392US7132551B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2003·Granted Nov 7, 2006·45 cites·17 claims
- 0491US8053603B2Tetralone-based monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2006·Granted Nov 8, 2011·24 cites·23 claims
- 0588US6677332B1Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2000·Granted Jan 13, 2004·22 cites·32 claims
- 0687US9427479B2Tubulysin derivativesMEDIMMUNE LLC·Filed 2015·Granted Aug 30, 2016·5 cites·41 claims
- 0786US6635661B2Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2001·Granted Oct 21, 2003·16 cites·26 claims
- 0884US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 0983US7816375B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2009·Granted Oct 19, 2010·4 cites·16 claims
- 1081US7129228B2Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2004·Granted Oct 31, 2006·9 cites·28 claims
- 1178US9133117B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Sep 15, 2015·2 cites·21 claims
- 1278US8592608B2Triple reuptake inhibitors and methods of their useSHAO LIMING·Filed 2009·Granted Nov 26, 2013·2 cites·25 claims
- 1378US7517892B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2001·Granted Apr 14, 2009·8 cites·16 claims
- 1477US8669291B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2008·Granted Mar 11, 2014·2 cites·19 claims
- 1577US7511073B2Amines that inhibit a mammalian anandamide transporter, and methods of use thereofSEPRACOR INC·Filed 2006·Granted Mar 31, 2009·2 cites·10 claims
- 1673US7049329B2Amines that inhibit a mammalian anandamide transporter, and methods of use thereofSEPRACOR INC·Filed 2003·Granted May 23, 2006·5 cites·16 claims
- 1769US8877975B2Cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2010·Granted Nov 4, 2014·1 cites·23 claims
- 1866US9586888B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·0 cites·27 claims
- 1965US9868718B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·0 cites·2 claims
- 2064US7671087B2Amines that inhibit a mammalian anandamide transporter, and methods of use thereofSEPRACOR INC·Filed 2009·Granted Mar 2, 2010·0 cites·16 claims
- 2163US10428021B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Oct 1, 2019·0 cites·11 claims
- 2263US2017204050A1Phenyl substituted cycloalkylamines as monoamine reputake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2360US2007203111A1Cycloalkylamines as monoamine reuptake inhibitorsSEPRACOR INC·Filed 2007·Application pending·0 cites
- 2457US10562878B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·0 cites·26 claims
- 2557US10159745B2Tubulysin derivativesMEDIMMUNE LLC·Filed 2016·Granted Dec 25, 2018·0 cites·18 claims
- 2655US9850204B2Triple reuptake inhibitors and methods of their useSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Dec 26, 2017·0 cites·23 claims
- 2750US6177572B1Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their useSEPRACOR INC·Filed 1997·Granted Jan 23, 2001·8 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Fengjiang Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →